-
1102 N Delaware Ave, Philadelphia, PA 19125 -
(215) 770 3007
- 9:00 AM – 9:00 PM
1102 N Delaware Ave, Philadelphia, PA 19125
(215) 770 3007
According to the National Institutes of Health, cannabis, commonly referred to as marijuana, has been used for medicinal purposes for over 3,000 years. In June 2018, the Food and Drug Administration approved a specific cannabinoid found in cannabis for the treatment of certain types of epilepsy. However, the FDA has not concluded that cannabis is either safe or effective in treating any other health conditions.
The ongoing push for the legalization of marijuana has intensified the debate between the widespread belief that cannabis is a beneficial treatment for various ailments and the limited scientific evidence available regarding its effects.
To assess the potential benefits of marijuana and determine its efficacy, we will examine the scientific data that has been gathered on this topic. This article aims to analyze the potential advantages of the medicinal wonder called “marijuana.”
Six cannabinoids, identified by researcher Wai Lu Senior, of St. George’s University, London, have been shown to inhibit or delay the growth of cancer cells and can even kill them.
Previous research has shown that THC (the active ingredient in marijuana) has powerful anti-cancer effects, but THC’s euphoric properties don’t mean it’s a good choice for this use. Wai Lu identified several cannabinoids with the ability to either kill cancer cells or inhibit their growth. He also found that combining these two cannabinoids significantly increases the potency of cannabis compared to using them on their own. Cannabis has been studied extensively over the years, and there are indications that it may be helpful in treating several conditions listed below.
A thorough analysis of the available data published in the Journal Clinical Psychology Review indicates that cannabis use may be beneficial for individuals suffering from alcohol or drug addiction.
However, this is still in the early stages of research. According to a study published in the Journal of Medicinal Products for Human Use, “Cannabis use may actually increase the risk for substance abuse and addiction to other drugs.”
Oral cannabis has only been studied for a short time, but it has been suggested that it may be effective in reducing spasticity, which is a common symptom of multiple sclerosis.
CBD, or Cannabidiol, found in other countries, has been shown to activate the body’s natural defences to fight a wide range of diseases, including cancer.
Cannabis has been used to treat a variety of conditions, including Alzheimer’s, multiple sclerosis, diabetes, Crohn’s, and more. A Canadian study found that cannabis can help people with neuropathic pain sleep better and reduce pain. It’s also being used to treat traumatic brain injury in Israel.
The review article, published in the peer-reviewed journal Clinical Psychology Review, reviewed all published studies on the use of marijuana for the treatment of symptoms of mental health disorders. The researchers found evidence to support the use of cannabis for the treatment of depression and PTSD.
The FDA granted marketing authorisation in June 2018 for a cannabinoid-based medication to treat two rare and difficult-to-manage forms of epilepsy. These two forms of epilepsy are known as Lennox-Gilmer syndrome (LGS) and Dravid syndrome (Dravet syndrome) and are characterized by their inability to be managed with other medications. The CBD-based medicine approved by the Administration is known as Epidiole.
In a review article published in Clinical Psychology Review, researchers reviewed all published studies exploring the potential of marijuana for the treatment of mental health conditions. While there is some evidence to support the use of cannabis for the treatment of depression and PTSD, the authors caution against its use for the treatment of a variety of mental health conditions, such as psychosis and bipolar disorder.
Research conducted in other countries has revealed the therapeutic potential of cannabis derivatives, such as CBD, which have been linked to the activation of the body’s innate defences against a range of conditions, including cancer and Alzheimer’s disease. Additionally, a Canadian study has demonstrated that cannabis can help patients with neuropathic pain achieve improved sleep and reduce discomfort. Additionally, research is being conducted in Israel to explore the potential of cannabis as a therapeutic tool in traumatic brain injury. This raises the question of why the US is overlooking the potential of this remarkable medical discovery.
To sum up, scientific evidence supports the negative and positive impacts of cannabis on human health. While comprehensive reviews of scientific studies examining the advantages and disadvantages of cannabis have recently been published, it is clear that further research is needed to fully understand the impact of increased cannabis use on public health.
